Steve Morrison, a medical biochemist by training, previously worked for more than 20 years in the pharmaceutical industry as a global project development leader (Shire Pharmaceuticals, Medeva, Wyeth Laboratories, Evans Medical Ltd, and Ipsen Limited) before becoming the Chief Operating Officer of AIM listed Provexis plc (2008-12).
Provexis plc made headlines in 2010 by becoming the first European functional food company to achieve an Article 13.5 ‘new science’ health claim from the European Food Safety Authority or EFSA (under the EC Regulation No:1924/2006). The Provexis plc claim was a “cardiovascular health” claim for the functional food ingredient, Fruitflow™ which is a water soluble extract of tomato and the specific health benefit related to the reduction of platelet aggregation in the blood.
Subsequently, Steve established P2F Ventures Ltd in 2012, an independent consultancy business that provides regulatory and product development consultancy in the area of health claims within the functional food/nutraceutical space. P2F Ventures has successfully supported client companies in fund raising efforts to support development plans and is known to a number of VC funds in UK/Europe.